These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 17514662)

  • 61. Antiplatelet 'resistance' and 'non-responders': what do these terms really mean?
    Serebruany VL; Eisert C; Atar D; Ferguson JJ
    Fundam Clin Pharmacol; 2009 Feb; 23(1):11-8. PubMed ID: 19267767
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The role of platelet activation in tumor metastasis.
    Borsig L
    Expert Rev Anticancer Ther; 2008 Aug; 8(8):1247-55. PubMed ID: 18699763
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Acquired platelet function disorders: pathogenesis, classification, frequency, diagnosis, clinical management].
    Scharf RE
    Hamostaseologie; 2008 Dec; 28(5):299-311. PubMed ID: 19132161
    [TBL] [Abstract][Full Text] [Related]  

  • 64. New potential therapies for the treatment of antiphospholipid syndrome.
    Saha AK; D'Cruz D
    Expert Opin Ther Pat; 2009 Jan; 19(1):13-22. PubMed ID: 19441895
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Haemostatic mechanisms in the process of atherotrombosis].
    Kvasnička T
    Vnitr Lek; 2012 Feb; 58(2):123-8. PubMed ID: 22463092
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Platelet-lymphocyte cross-talk.
    Li N
    J Leukoc Biol; 2008 May; 83(5):1069-78. PubMed ID: 18198208
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Evaluation of dose-related effects of aspirin on platelet function: results from the Aspirin-Induced Platelet Effect (ASPECT) study.
    Gurbel PA; Bliden KP; DiChiara J; Newcomer J; Weng W; Neerchal NK; Gesheff T; Chaganti SK; Etherington A; Tantry US
    Circulation; 2007 Jun; 115(25):3156-64. PubMed ID: 17562955
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Clinical significance of platelet size in inflammatory bowel disease?
    Collins CE; Cahill MR; Rampton DS
    Thromb Haemost; 1997 Jan; 77(1):218-9. PubMed ID: 9031479
    [No Abstract]   [Full Text] [Related]  

  • 69. Platelet function in intravascular device implant-induced intimal injury.
    Tesfamariam B
    Cardiovasc Revasc Med; 2008; 9(2):78-87. PubMed ID: 18486081
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Relationship between high platelet turnover and platelet function in high-risk patients with coronary artery disease on dual antiplatelet therapy.
    Cesari F; Marcucci R; Caporale R; Paniccia R; Romano E; Gensini GF; Abbate R; Gori AM
    Thromb Haemost; 2008 May; 99(5):930-5. PubMed ID: 18449424
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Increased platelet sensitivity among individuals with aspirin resistance - platelet aggregation to submaximal concentration of arachidonic acid predicts response to antiplatelet therapy.
    Guthikonda S; Mangalpally K; Vaduganathan M; Patel R; Delao T; Bergeron AL; Dong JF; Lev EI; Kleiman NS
    Thromb Haemost; 2008 Jul; 100(1):83-9. PubMed ID: 18612542
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Platelets in liver transplantation: friend or foe?
    Pereboom IT; Lisman T; Porte RJ
    Liver Transpl; 2008 Jul; 14(7):923-31. PubMed ID: 18581510
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Platelet activation and its patient-specific consequences.
    Smyth SS; Monroe DM; Wysokinski WE; McBane RD; Whiteheart SW; Becker RC; Steinhubl SR
    Thromb Res; 2008; 122(4):435-41. PubMed ID: 17949794
    [TBL] [Abstract][Full Text] [Related]  

  • 74. A comparison of six major platelet function tests to determine the prevalence of aspirin resistance in patients with stable coronary artery disease.
    Lordkipanidzé M; Pharand C; Schampaert E; Turgeon J; Palisaitis DA; Diodati JG
    Eur Heart J; 2007 Jul; 28(14):1702-8. PubMed ID: 17569678
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Stroke and atherothrombosis: an update on the role of antiplatelet therapy.
    Alexandrov AV; Alagona P
    Int J Stroke; 2008 Aug; 3(3):175-81. PubMed ID: 18705896
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Anti-thrombotic therapy in diabetic patients: revisited.
    Stratmann B; Tschoepe D
    Expert Rev Cardiovasc Ther; 2011 Mar; 9(3):253-5. PubMed ID: 21438800
    [No Abstract]   [Full Text] [Related]  

  • 77. Evaluation of the platelet count drop method for assessment of platelet function in comparison with "gold standard" light transmission aggregometry.
    Lordkipanidzé M; Pharand C; Schampaert E; Palisaitis DA; Diodati JG
    Thromb Res; 2009 Sep; 124(4):418-22. PubMed ID: 19250657
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Effect of the acetylosalicyd acid (ASA) and ticlopidine therapy on clinical condition and parameters of blood platelets in patients with peripheral arterial occlusive disease (PAOD)].
    Leo W; Westrych R; Bissinger A; Okraszewski J; Baj Z
    Pol Merkur Lekarski; 2007 Nov; 23(137):335-9. PubMed ID: 18361314
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Surgical procedures in patients treated with platelet function inhibitors].
    Rupprecht HJ; Blank R; Konradi D; Andreas K; Auerbach H
    Herz; 2008 Jun; 33(4):254-9. PubMed ID: 18581074
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [A current problem in atherothrombotic diseases--aspirin resistance: definition, mechanisms, determination with laboratory tests and clinical implications].
    Pamukçu B; Oflaz H; Nişanci Y
    Anadolu Kardiyol Derg; 2007 Dec; 7 Suppl 2():20-6. PubMed ID: 18160363
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.